Your request to link to rcsb for BDBM50030474

• 1FM6: the 2.1 angstrom resolution crystal structure of the heterodimer of the human rxralpha and ppargamma ligand binding domains respectively bound with 9-cis retinoic acid and rosiglitazone and co-activator peptides. (10.1016/S1097-2765(00)80448-7 )
• 1ZGY: structural and biochemical basis for selective repression of the orphan nuclear receptor lrh-1 by shp (10.1073/PNAS.0501204102 )
• 3CS8: structural and biochemical basis for the binding selectivity of pparg to pgc-1a (10.1074/JBC.M802040200 )
• 5JI0: ppargamma-rxralpha(s427f) heterodimer in complex with src-1, rosiglitazone, and 9-cis-retanoic acid
• 5YCP: human ppargamma ligand binding domain complexed with rosiglitazone (10.1038/S41598-017-18274-1 )
• 4EMA: human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone (10.1371/JOURNAL.PONE.0036297 )
• 6MD4: crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid (10.7554/ELIFE.43320 )
• 4XLD: crystal structure of the human pparg-lbd/rosiglitazone complex obtained by dry co-crystallization and in situ diffraction (10.1107/S1399004715010342 )
• 3DZY: intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide (10.1038/NATURE07413 )
• 7AWC: crystal structure of peroxisome proliferator-activated receptor gamma (pparg)in complex with rosiglitazone
• 6ONJ: crystal structure of ppargamma ligand binding domain in complex with trap220 peptide and agonist rosiglitazone (10.1038/S41467-020-14750-X )
• 4O8F: crystal structure of the complex between ppargamma mutant r357a and rosiglitazone (10.1107/S1399004714009638 )
• 2PRG: ligand-binding domain of the human peroxisome proliferator activated receptor gamma (10.1038/25931 )